Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response. | Clin Mol Hepatol;2024 Aug 30. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Brasil - Virtual Health Library

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response.

Kanzaki, Hiroaki; Hoshida, Yujin.

Affiliation

Kanzaki H; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hoshida Y; Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, U.S.

Clin Mol Hepatol ; 2024 Aug 30.

Article in En | MEDLINE | ID: mdl-39218442

Key words

immunotherapy; molecular signatures; predictive biomarker; hepatocellular carcinoma

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Mol Hepatol / Clin. mol. hepatol (Online) / Clinical and molecular hepatology (Online) Year: 2024 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Mol Hepatol / Clin. mol. hepatol (Online) / Clinical and molecular hepatology (Online) Year: 2024 Document type: Article